181 related articles for article (PubMed ID: 36158701)
1. Broad genomic workup including optical genome mapping uncovers a
Nilius-Eliliwi V; Tembrink M; Gerding WM; Lubieniecki KP; Lubieniecka JM; Kankel S; Liehr T; Mika T; Dimopoulos F; Döhner K; Schroers R; Nguyen HHP; Vangala DB
Front Oncol; 2022; 12():959243. PubMed ID: 36158701
[TBL] [Abstract][Full Text] [Related]
2. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
[TBL] [Abstract][Full Text] [Related]
3. Novel
Tembrink M; Gerding WM; Wieczorek S; Mika T; Schroers R; Nguyen HP; Vangala DB; Nilius-Eliliwi V
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296904
[TBL] [Abstract][Full Text] [Related]
4. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
[TBL] [Abstract][Full Text] [Related]
5. Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia.
Suttorp J; Lühmann JL; Behrens YL; Göhring G; Steinemann D; Reinhardt D; Neuhoff NV; Schneider M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565187
[TBL] [Abstract][Full Text] [Related]
6. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
[TBL] [Abstract][Full Text] [Related]
7. Optical Genome Mapping for Cytogenetic Diagnostics in AML.
Nilius-Eliliwi V; Gerding WM; Schroers R; Nguyen HP; Vangala DB
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980569
[TBL] [Abstract][Full Text] [Related]
8. Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.
Boddu PC; Kadia TM; Garcia-Manero G; Cortes J; Alfayez M; Borthakur G; Konopleva M; Jabbour EJ; Daver NG; DiNardo CD; Naqvi K; Yilmaz M; Short NJ; Pierce S; Kantarjian HM; Ravandi F
Cancer; 2019 Apr; 125(7):1091-1100. PubMed ID: 30521114
[TBL] [Abstract][Full Text] [Related]
9. Acute leukemia with PICALM-MLLT10 fusion gene: diagnostic and treatment struggle.
Savage NM; Kota V; Manaloor EJ; Kulharya AS; Pierini V; Mecucci C; Ustun C
Cancer Genet Cytogenet; 2010 Oct; 202(2):129-32. PubMed ID: 20875875
[TBL] [Abstract][Full Text] [Related]
10. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
11. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an IGH deletion.
Hare L; Trotman J; Tarpey P; Hook E; Burke GAA;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30810. PubMed ID: 38102963
[TBL] [Abstract][Full Text] [Related]
12. Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Döhner K; Thiede C; Jahn N; Panina E; Gambietz A; Larson RA; Prior TW; Marcucci G; Jones D; Krauter J; Heuser M; Voso MT; Ottone T; Nomdedeu JF; Mandrekar SJ; Klisovic RB; Wei AH; Sierra J; Sanz MA; Brandwein JM; de Witte T; Jansen JH; Niederwieser D; Appelbaum FR; Medeiros BC; Tallman MS; Schlenk RF; Ganser A; Serve H; Ehninger G; Amadori S; Gathmann I; Benner A; Pallaud C; Stone RM; Döhner H; Bloomfield CD
Blood; 2020 Jan; 135(5):371-380. PubMed ID: 31826241
[TBL] [Abstract][Full Text] [Related]
13. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.
Garg M; Nagata Y; Kanojia D; Mayakonda A; Yoshida K; Haridas Keloth S; Zang ZJ; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ding LW; Alpermann T; Sun QY; Lin DC; Chien W; Madan V; Liu LZ; Tan KT; Sampath A; Venkatesan S; Inokuchi K; Wakita S; Yamaguchi H; Chng WJ; Kham SK; Yeoh AE; Sanada M; Schiller J; Kreuzer KA; Kornblau SM; Kantarjian HM; Haferlach T; Lill M; Kuo MC; Shih LY; Blau IW; Blau O; Yang H; Ogawa S; Koeffler HP
Blood; 2015 Nov; 126(22):2491-501. PubMed ID: 26438511
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
[TBL] [Abstract][Full Text] [Related]
15. Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns.
Guan W; Zhou L; Li Y; Yang E; Liu Y; Lv N; Fu L; Ding Y; Wang N; Fang N; Liu Q; Wang B; Li F; Zhang J; Wang M; Wang L; Jing Y; Li Y; Yu L
Exp Hematol Oncol; 2021 Apr; 10(1):27. PubMed ID: 33836835
[TBL] [Abstract][Full Text] [Related]
16. Optical Genome Mapping for Comprehensive Assessment of Chromosomal Aberrations and Discovery of New Fusion Genes in Pediatric B-Acute Lymphoblastic Leukemia.
Gao H; Xu H; Wang C; Cui L; Huang X; Li W; Yue Z; Tian S; Zhao X; Xue T; Xing T; Li J; Wang Y; Zhang R; Li Z; Wang T
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612032
[TBL] [Abstract][Full Text] [Related]
17. New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia.
Brandimarte L; Pierini V; Di Giacomo D; Borga C; Nozza F; Gorello P; Giordan M; Cazzaniga G; Te Kronnie G; La Starza R; Mecucci C
Blood; 2013 Jun; 121(25):5064-7. PubMed ID: 23673860
[TBL] [Abstract][Full Text] [Related]
18. TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
Metzeler KH; Maharry K; Radmacher MD; Mrózek K; Margeson D; Becker H; Curfman J; Holland KB; Schwind S; Whitman SP; Wu YZ; Blum W; Powell BL; Carter TH; Wetzler M; Moore JO; Kolitz JE; Baer MR; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
J Clin Oncol; 2011 Apr; 29(10):1373-81. PubMed ID: 21343549
[TBL] [Abstract][Full Text] [Related]
19. Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients.
Gatua M; Navari M; Ong'ondi M; Onyango N; Kaggia S; Rogena E; Visani G; Abinya NA; Piccaluga PP
Front Genet; 2022; 13():843705. PubMed ID: 35836575
[TBL] [Abstract][Full Text] [Related]
20. Clonal heterogeneity of
Schranz K; Hubmann M; Harin E; Vosberg S; Herold T; Metzeler KH; Rothenberg-Thurley M; Janke H; Bräundl K; Ksienzyk B; Batcha AMN; Schaaf S; Schneider S; Bohlander SK; Görlich D; Berdel WE; Wörmann BJ; Braess J; Krebs S; Hiddemann W; Mansmann U; Spiekermann K; Greif PA
Oncotarget; 2018 Jul; 9(53):30128-30145. PubMed ID: 30046393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]